Homeβ€ΊSearchβ€ΊHaematologica

Haematologica

Ferrata Storti Foundation Β· Italy

ISSN1592-8721
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
8
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1 Β· Scopus CiteScore 11.3. Source: Clarivate Journal Citation Reports.

SJR Scorei
2.534
H-Indexi
182
CiteScorei
11.3
SNIPi
1.503
Total Worksi
9,021
Total Citationsi
298,064
2yr Mean Citednessi
1.58
Open Impact Factor alternative
Retractions
10
Source: Retraction Watch

Aims & Scope

Haematologica is the main tool through which the Ferrata-Storti Foundation, a non-profit organization, promotes the dissemination of new knowledge in the field of hematology. A high quality of articles, immediate free access to everything published and the lowest possible cost for authors are the principles that inspire Haematologica's management. Haematologica considers for publication manuscripts on malignant and non-malignant hematologic diseases, including hemostasis defects. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment. Clinical studies on drugs that modify the hemostatic process for antihemorrhagic or antithrombotic purposes fall within the field of interest of Haematologica. Basic studies on hematopoiesis, blood cells, hemostasis and blood banking that have the potential for clinical relevance are also considered for publication. Haematologica does not publish the results of studies that have already been published, even partially, or are going to be published in any form, except for meeting abstracts and manuscripts released as a preprint before or during submission.

General Information

Country / RegionItaly
Primary LanguageEnglish
1st Year Publishedβ€”
FrequencyMonthly, 1998-
StatusActive
Total Publications9,021
Publisher OrgFerrata Storti Foundation
Visit Journal Website

Submission Info

Peer ReviewPeer review
Review Time~8 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ— No

Think.Check.Submit Compliance

8/12 Β· 67%
βœ…
Do you know the journal / publisher?
Ferrata Storti Foundation
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1592-8721
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Peer review
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
No
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
615
22k
2019
547
17k
2020
328
7.2k
2021
406
6.1k
2022
448
4.7k
2023
476
2.1k
2024
543
585
2025
614
49
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

HematologyQ1

Subject Classification

Web of Science Categories

Hematology

Scopus Categories

Hematology

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationMyeloproliferative Neoplasms: Diagnosis and TreatmentHemoglobinopathies and Related DisordersPlatelet Disorders and Treatments

Frequently asked questions about Haematologica

Is Haematologica a predatory journal?

PubScope has no integrity flags on record for Haematologica: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Haematologica?

Haematologica is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 11.3.

Is Haematologica indexed in Scopus and Web of Science?

Haematologica is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Haematologica?

Haematologica is the main tool through which the Ferrata-Storti Foundation, a non-profit organization, promotes the dissemination of new knowledge in the field of hematology. A high quality of articles, immediate free access to everything published and the lowest possible cost for authors are the principles that inspire Haematologica's management. Haematologica considers for publication manuscripts on malignant and non-malignant hematologic diseases, including hemostasis defects. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatme

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref